DE69715668T2 - N-(pyridinylamino)isoindoline und verwandte verbindungen - Google Patents

N-(pyridinylamino)isoindoline und verwandte verbindungen

Info

Publication number
DE69715668T2
DE69715668T2 DE69715668T DE69715668T DE69715668T2 DE 69715668 T2 DE69715668 T2 DE 69715668T2 DE 69715668 T DE69715668 T DE 69715668T DE 69715668 T DE69715668 T DE 69715668T DE 69715668 T2 DE69715668 T2 DE 69715668T2
Authority
DE
Germany
Prior art keywords
pyridinylamino
related compounds
isoindoline
isoindolines
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715668T
Other languages
English (en)
Other versions
DE69715668D1 (de
Inventor
E Kurys
M Fink
S Freed
H Merriman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/959,789 external-priority patent/US6004977A/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69715668D1 publication Critical patent/DE69715668D1/de
Publication of DE69715668T2 publication Critical patent/DE69715668T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
DE69715668T 1996-12-27 1997-11-13 N-(pyridinylamino)isoindoline und verwandte verbindungen Expired - Fee Related DE69715668T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77430896A 1996-12-27 1996-12-27
US08/959,789 US6004977A (en) 1996-12-27 1997-10-29 N-(pyridinylamino) isoindolines and related compounds
PCT/US1997/020591 WO1998029407A2 (en) 1996-12-27 1997-11-13 N-(pyridinylamino)isoindolines for treating alzheimer's and depression

Publications (2)

Publication Number Publication Date
DE69715668D1 DE69715668D1 (de) 2002-10-24
DE69715668T2 true DE69715668T2 (de) 2003-07-31

Family

ID=27118867

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715668T Expired - Fee Related DE69715668T2 (de) 1996-12-27 1997-11-13 N-(pyridinylamino)isoindoline und verwandte verbindungen

Country Status (15)

Country Link
EP (1) EP0950056B1 (de)
JP (1) JP4256937B2 (de)
KR (1) KR20000062358A (de)
AT (1) ATE224387T1 (de)
AU (1) AU720466B2 (de)
BR (1) BR9714189A (de)
CA (1) CA2276203C (de)
DE (1) DE69715668T2 (de)
DK (1) DK0950056T3 (de)
ES (1) ES2179377T3 (de)
HU (1) HUP0000783A2 (de)
IL (1) IL130642A0 (de)
NO (1) NO993180L (de)
PT (1) PT950056E (de)
WO (1) WO1998029407A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6772195B1 (en) 1999-10-29 2004-08-03 Electronic Arts, Inc. Chat clusters for a virtual world application
AU2001256733A1 (en) * 2000-05-16 2001-11-26 Takeda Chemical Industries Ltd. Melanin-concentrating hormone antagonist
KR20060009686A (ko) * 2004-07-26 2006-02-01 엘지이노텍 주식회사 반도체 발광소자 및 그 제조방법
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
KR20160020584A (ko) 2007-01-22 2016-02-23 지티엑스, 인코포레이티드 핵 수용체에 결합하는 물질

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
DE69016531T2 (de) * 1989-08-02 1995-07-06 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5102891A (en) * 1990-07-23 1992-04-07 Hoechst-Roussel Pharmaceuticals Inc. 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles

Also Published As

Publication number Publication date
CA2276203A1 (en) 1998-07-09
ES2179377T3 (es) 2003-01-16
NO993180D0 (no) 1999-06-25
PT950056E (pt) 2002-12-31
EP0950056A2 (de) 1999-10-20
IL130642A0 (en) 2000-06-01
ATE224387T1 (de) 2002-10-15
DK0950056T3 (da) 2003-01-27
CA2276203C (en) 2003-07-22
NO993180L (no) 1999-08-26
AU5434998A (en) 1998-07-31
BR9714189A (pt) 2000-02-29
WO1998029407A3 (en) 1998-10-22
JP2001511119A (ja) 2001-08-07
KR20000062358A (ko) 2000-10-25
JP4256937B2 (ja) 2009-04-22
WO1998029407A2 (en) 1998-07-09
DE69715668D1 (de) 2002-10-24
HUP0000783A2 (hu) 2001-04-28
AU720466B2 (en) 2000-06-01
EP0950056B1 (de) 2002-09-18

Similar Documents

Publication Publication Date Title
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
ATE177420T1 (de) Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase
NO20006645D0 (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
BG104780A (en) Inhibitors of phospholipase enzymes
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
PT966465E (pt) Inibidores do enzima imfdh
BR9707819A (pt) Imunogenos peptidicos
AU9102198A (en) Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
AP9901478A0 (en) Compounds for the treatment of ischemia.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
BG105028A (en) Bridged indenopyrrolocarbazoles
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
DE69937301D1 (de) Aminosterolderivate und ihre verwendungen
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DE69715668D1 (de) N-(pyridinylamino)isoindoline und verwandte verbindungen
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
WO1988003927A3 (en) Renin inhibitors
NO943765L (no) Aryloksybenzen-herbicidmidler
ATE247955T1 (de) Selenophen-antitumormittel
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
DE69333270D1 (de) Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
MX9709450A (es) Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8339 Ceased/non-payment of the annual fee